A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
Clinical trial NCT02556463 · TERMINATED
Trial details
- NCT number
- NCT02556463
- Sponsor
- MedImmune LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-04
- Primary completion
- 2018-10-26
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.